Benidipine Hydrochloride Tablets 4mg (Benidipine Hydrochloride Tablets “Sawai”® / ベニジピン塩酸塩錠4mg「サワイ」)

JPY ¥1,800

Japanese long-acting calcium channel blocker (Benidipine Hydrochloride 4mg). Oral tablet for hypertension, renal parenchymal hypertension, and angina pectoris. PTP: 100 tablets (10 tablets x 10). Mfd. by Medisa Shinyaku Inc., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,656
10 - 19 12% JPY ¥1,584
20 + 18% JPY ¥1,476
SKU: BEN-4-TAB Category:

Description

Product Overview / 商品概要

Benidipine Hydrochloride Tablets 4mg “Sawai” (ベニジピン塩酸塩錠4mg「サワイ」)
Generic: Benidipine Hydrochloride / ベニジピン塩酸塩
Therapeutic Category: Long-acting Calcium Channel Blocker; Antihypertensive and Antianginal Agent / 持続性Ca拮抗剤 高血圧症・狭心症治療剤
Manufactured by: Medisa Shinyaku Inc. / メディサ新薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Benidipine Hydrochloride (JP) 4mg per tablet / 1錠中 日局ベニジピン塩酸塩 4mg
Additives: Carnauba wax, Titanium dioxide, Ferric oxide, Magnesium stearate, Lactose, Potato starch, Hypromellose, Polyvinyl alcohol (partially saponified), Macrogol 6000, Talc / カルナウバロウ、酸化チタン、三二酸化鉄、ステアリン酸Mg、乳糖、バレイショデンプン、ヒプロメロース、ポリビニルアルコール(部分けん化物)、マクロゴール6000、タルク
Appearance: Yellow, scored film-coated tablet; diameter 7.1mm, thickness 3.3mm, weight approx. 138mg; identification code: SW BN4
外観: 黄色、割線入りフィルムコーティング錠、直径7.1mm、厚さ3.3mm、重量約138mg、識別表示: SW BN4

Indications / 効能効果

EN: Hypertension, Renal parenchymal hypertension, Angina pectoris
JA: 高血圧症、腎実質性高血圧症、狭心症

Dosage and Administration / 用法用量

EN: Usually, adults take 2 to 4mg orally once daily after breakfast. Dose may be adjusted according to age and symptoms; if effect is insufficient, dose may be increased up to 8mg once daily. For severe hypertension, 4 to 8mg once daily after breakfast. Usually, adults take 4mg orally twice daily after breakfast and evening meal. Dose may be adjusted according to age and symptoms.
JA: 〈高血圧症、腎実質性高血圧症〉通常、成人にはベニジピン塩酸塩として1日1回2~4mgを朝食後経口投与する。なお、年齢、症状により適宜増減するが、効果不十分な場合には、1日1回8mgまで増量することができる。ただし、重症高血圧症には1日1回4~8mgを朝食後経口投与する。〈狭心症〉通常、成人にはベニジピン塩酸塩として1回4mgを1日2回朝・夕食後経口投与する。なお、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with cardiogenic shock; pregnant women or women who may be pregnant
JA: 心原性ショックの患者、妊婦又は妊娠している可能性のある女性

Regulatory Information / 規制情報

Approval No.: 21800AMZ10078000
Sales Started: July 2006 / 2006年7月
Classification Code: 872179
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): PTP: 100 tablets (10 tablets x 10) / PTP:100錠(10錠×10)
Other Available Packages (by special order): PTP: 100 tablets (10 tablets x 10), 500 tablets (10 tablets x 50); Bulk: 500 tablets

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Benidipine Hydrochloride Tablets 4mg (Benidipine Hydrochloride Tablets “Sawai”® / ベニジピン塩酸塩錠4mg「サワイ」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Benidipine Hydrochloride Tablets 4mg (Benidipine Hydrochloride Tablets "Sawai"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.